About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
ICPT - Intercept Pharmaceut...| Previous Close | $37.39 | Open | $37.55 |
| Volume | 424.4K | Market Cap | 1.234B |
| Yield | Last Dividend |
| ROSEN, GLOBAL INVESTOR COUNSEL, Reminds ... | 11/26/20 |
| NEW YORK, Nov. 26, 2020 (GLOBE NEWSWIRE) ??? Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Phar... | |
| ROSEN, A LEADING LAW FIRM, Reminds Inter... | 11/24/20 |
| NEW YORK, Nov. 24, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceu... | |
| ROSEN, GLOBALLY RECOGNIZED INVESTOR COUN... | 11/20/20 |
| NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. ... | |
| Bragar Eagel & Squire, P.C. Reminds Inve... | 11/18/20 |
| NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) ??? Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that ... | |
| ICPT Shareholder Alert: Bronstein, Gewir... | 11/17/20 |
| NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Intercept Pharmace... | |
| New Data from the Interim Analysis of RE... | 11/16/20 |
| Multiple new analyses reinforce the clinical value of noninvasive strategies to identify and monitor patients with advanced fibrosis due to NASHNEW YO... | |
| ROSEN, RESPECTED INVESTOR COUNSEL, Annou... | 11/14/20 |
| NEW YORK, Nov. 14, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of... | |
| Deadline Reminder: Law Offices of Howard... | 11/13/20 |
| BENSALEM, Pa.???(BUSINESS WIRE)???$ICPT #CLASSACTION???Law Offices of Howard G. Smith reminds investors of the upcoming January 4, 2021 deadline to fi... | |
| Scott+Scott Attorneys at Law LLP Reminds... | 11/13/20 |
| NEW YORK--(BUSINESS WIRE)-- #ICPT--Scott+Scott Attorneys at Law LLP Reminds Investors of Securities Class Action against Intercept Pharmaceuticals, In... | |
| Bragar Eagel & Squire, P.C. Reminds Inve... | 11/11/20 |
| NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) ??? Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that ... | |
| Glancy Prongay & Murray LLP Reminds Inve... | 11/11/20 |
| LOS ANGELES--(BUSINESS WIRE)---- $ICPT #CLASSACTION--Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Aga... | |
| ICPT Investor Alert: Bronstein, Gewirtz ... | 11/10/20 |
| NEW YORK, Nov. 10, 2020 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has b... | |
| ROSEN, A LEADING AND LONGSTANDING LAW FI... | 11/09/20 |
| NEW YORK???(BUSINESS WIRE)???Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers... | |
| The Law Offices of Frank R. Cruz Announc... | 11/09/20 |
| LOS ANGELES--(BUSINESS WIRE)---- $ICPT #classaction--The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf o... | |
| Intercept Pharmaceuticals: Q3 Earnings I... | 11/09/20 |
| Shares of Intercept Pharmaceuticals (NASDAQ:ICPT) rose 2.9% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings ??... | |
| SHAREHOLDER ACTION ALERT: The Schall Law... | 11/08/20 |
| SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Intercept Pharmaceuticals, Inc. | |
| Pomerantz Law Firm Announces the Filing ... | 11/07/20 |
| NEW YORK, Nov. 07, 2020 (GLOBE NEWSWIRE) ??? Pomerantz LLP announces that a class action lawsuit has been filed against Intercept Pharmaceuticals, Inc... | |
| ICPT INVESTOR DEADLINE ALERT: Bernstein ... | 11/06/20 |
| NEW YORK , Nov. 6, 2020 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file... | |
| Glancy Prongay & Murray LLP, a Leading S... | 11/06/20 |
| LOS ANGELES--(BUSINESS WIRE)---- $ICPT #CLASSACTION--Glancy Prongay & Murray, a Leading Law Firm, Announces Filing of Securities Class Action on Behal... | |
| INTERCEPT PHARMACEUTICALS ALERT: Bragar ... | 11/05/20 |
| NEW YORK, Nov. 05, 2020 (GLOBE NEWSWIRE) ??? Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class ... | |
| Intercept to Announce Third Quarter 2020... | 11/02/20 |
| NEW YORK, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and?... | |
| Scott+Scott Attorneys at Law LLP Announc... | 10/29/20 |
| Share this Stock InformationNEW YORK, Oct. 29, 2020 /PRNewswire/ ??? Scott+Scott Attorneys at Law LLP (???Scott+Scott???), an international shareholde... | |
| The Law Offices of Frank R. Cruz Announc... | 10/29/20 |
| LOS ANGELES--(BUSINESS WIRE)---- $ICPT #classaction--The Law Offices of Frank R. Cruz announces an investigation of Intercept Pharmaceuticals, Inc. (?... | |
| Glancy Prongay & Murray LLP, a Leading S... | 10/28/20 |
| LOS ANGELES--(BUSINESS WIRE)---- $ICPT #CLASSACTION--Glancy Prongay & Murray, Leading Securities Fraud Law Firm, Announces Investigation of Intercept ... | |
| INTERCEPT PHARMACEUTICALS ALERT: Bragar ... | 10/23/20 |
| Share this Stock Information NEW YORK, Oct. 23, 2020 (GLOBE NEWSWIRE) ??? Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law ... | |
| Global Non-Alcoholic Steatohepatitis Man... | 10/23/20 |
| ???Global Non-Alcoholic Steatohepatitis Management Market???Industry Trends and Forecast to 2026??? New Research Report Added to Databridgemarketresea... | |
| INVESTIGATION ALERT: The Schall Law Firm... | 10/22/20 |
| LOS ANGELES--(BUSINESS WIRE)---- $ICPT #ICPT--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Intercept Pharmace... | |
| The Daily Biotech Pulse: Prothena Progre... | 10/21/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 20) Ail... | |
| Intercept Pharmaceuticals (NASDAQ:ICPT) ... | 10/20/20 |
| Shares of Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) were down 5.9% on Tuesday . The company traded as low as $30.30 and last traded at $30.38. App... | |
| Intercept Pharmaceuticals, Inc. (NASDAQ:... | 10/20/20 |
| Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) was the recipient of a large increase in short interest in the month of September. As of September 30th,... | |
| Hold rating | 11/11/20 |
| Canaccord Genuity maintains Hold rating and raises Price Target from $42.00 to $58.00 | |
| Buy rating | 11/10/20 |
| Chardan Capital maintains Buy rating and lowers Price Target from $105.00 to $58.00 | |
| Buy rating | 11/10/20 |
| SVB Leerink maintains Market Perform rating and lowers Price Target from $50.00 to $48.00 | |
| Strong Buy rating | 11/10/20 |
| Baird upgrades from Neutral to Outperform rating and announces Price Target of $52.00 | |
| Strong Buy rating | 11/10/20 |
| Raymond James upgrades from Market Perform to Outperform rating and announces Price Target of $60.00 | |
| Hold rating | 11/10/20 |
| Credit Suisse maintains Neutral rating and lowers Price Target from $60.00 to $42.00 | |
| Date | 2020-11-09 (BMO) | Est. (EPS/Rev.) | ($1.93)/ 78.63M |
| Actual (EPS/Rev.) | $-1.61/ $79.52 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Swing it | Lee | 82.00 % | Follow |
| Option Ripper | Option Ripper | 34.00 % | Follow |
| Optioneering-W | Sam Allen | 33.00 % | Follow |
| Biotechnology | Robert Gadimian | 26.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
